{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T06:49:45Z","timestamp":1781938185790,"version":"3.54.5"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T00:00:00Z","timestamp":1504656000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0183656","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T17:40:18Z","timestamp":1504719618000},"page":"e0183656","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Cryptococcal antigen screening by lay cadres using a rapid test at the point of care: A feasibility study in rural Lesotho"],"prefix":"10.1371","volume":"12","author":[{"given":"Fernanda","family":"Rick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aline Aurore","family":"Niyibizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Shroufi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazumi","family":"Onami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah-Jane","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malehlohonolo","family":"Kuleile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Innocent","family":"Muleya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Chiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Van Cutsem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,9,6]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/cid\/cit724","article-title":"Advanced HIV disease at entry into HIV care and initiation of antiretroviral therapy during 2006\u20132011: findings from four sub-saharan African countries","volume":"58","author":"M Lahuerta","year":"2014","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1097\/QAD.0b013e32830007cd","article-title":"Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa","volume":"22","author":"SD Lawn","year":"2008","journal-title":"AIDS"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(15)60164-7","article-title":"Cryptococcal meningitis screening and community-based early adherence support in people with advanced HIV infection starting antiretroviral therapy in Tanzania and Zambia: an open-label, randomised controlled trial","volume":"385","author":"S Mfinanga","journal-title":"The Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7196\/SAMJ.4378","article-title":"Poor long-term outcomes for cryptococcal meningitis in rural South Africa","volume":"101","author":"RJ Lessells","year":"2011","journal-title":"S Afr Med J"},{"key":"ref5","unstructured":"WHO (2011) Cryptococcal Guidleine Working Groups. Rapid advice: Diagnosis, prevention and management of cryptococcal disease in HIV- infected adults, adolescents and children."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1086\/597262","article-title":"Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa","volume":"48","author":"JN Jarvis","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1111\/j.1365-3156.2007.01874.x","article-title":"Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda","volume":"12","author":"CA Liechty","year":"2007","journal-title":"Trop Med Int Health"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40475-015-0045-z","article-title":"Preventing Cryptococcosis\u2014Shifting the Paradigm in the Era of Highly Active Antiretroviral Therapy","volume":"2","author":"D Meya","year":"2015","journal-title":"Current Tropical Medicine Reports"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1086\/655143","article-title":"Cost-effectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells\/microL who start HIV therapy in resource-limited settings","volume":"51","author":"DB Meya","year":"2010","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1097\/QAD.0b013e3283383aeb","article-title":"Testing but not treating: missed opportunities and lost lives in the South African antiretroviral therapy programme","volume":"24","author":"JN Jarvis","year":"2010","journal-title":"Aids"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1086\/657405","article-title":"Cryptococcal Antigen Screening for Patients Initiating Antiretroviral Therapy: Time for Action","volume":"51","author":"JN Jarvis","year":"2010","journal-title":"Clinical Infectious Diseases"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.7196\/SAMJ.6228","article-title":"Phased implementation of screening for cryptococcal disease in South Africa","author":"NP Govender","year":"2012"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa1312884","article-title":"Timing of Antiretroviral Therapy after Diagnosis of Cryptococcal Meningitis","volume":"370","author":"DR Boulware","year":"2014","journal-title":"New England Journal of Medicine"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1128\/CVI.00446-12","article-title":"Comparison of Four Assays for the Detection of Cryptococcal Antigen","volume":"19","author":"MJ Binnicker","year":"2012","journal-title":"Clinical and Vaccine Immunology: CVI"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"e49541","DOI":"10.1371\/journal.pone.0049541","article-title":"Clinical Utility of the Cryptococcal Antigen Lateral Flow Assay in a Diagnostic Mycology Laboratory","volume":"7","author":"BJ McMullan","year":"2012","journal-title":"PLoS ONE"},{"key":"ref16","unstructured":"Lesotho Ministry Of Health (2014) National Guidelines for HIV & AIDS Care and Treatment (4t h Edition)."},{"key":"ref17","unstructured":"UNAIDS HIV and AIDS estimates (2015)."},{"key":"ref18","unstructured":"Lesotho Ministry of Health (2014) The 2014 Lesotho Demographic and Health Survey"},{"key":"ref19","first-page":"78","article-title":"NATIONAL GUIDELINES ON THE USE OF ANTIRETROVIRAL THERAPY FOR HIV PREVENTION AND TREATMENT","volume":"7","author":"G Lesotho","year":"2014"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/tmi.12157","article-title":"Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay","volume":"18","author":"J Rugemalila","year":"2013","journal-title":"Trop Med Int Health"},{"issue":"Suppl 3","key":"ref21","doi-asserted-by":"crossref","first-page":"S331","DOI":"10.1097\/QAI.0000000000000484","article-title":"Cryptococcal antigen screening and early antifungal treatment to prevent cryptococcal meningitis: a review of the literature","volume":"68","author":"JE Kaplan","year":"2015","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.7448\/IAS.17.1.19040","article-title":"Utility of urine and serum lateral flow assays to determine the prevalence and predictors of cryptococcal antigenemia in HIV-positive outpatients beginning antiretroviral therapy in Mwanza, Tanzania","volume":"Vol 17","author":"KA Magambo","year":"2014","journal-title":"Journal of the International AIDS Society"},{"issue":"Suppl 3","key":"ref23","doi-asserted-by":"crossref","first-page":"S107","DOI":"10.1093\/infdis\/jit610","article-title":"Sex bias in the outcome of human tropical infectious diseases: influence of steroid hormones","volume":"209","author":"H Bernin","year":"2014","journal-title":"J Infect Dis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"e69288","DOI":"10.1371\/journal.pone.0069288","article-title":"Cost Effectiveness of Cryptococcal Antigen Screening as a Strategy to Prevent HIV-Associated Cryptococcal Meningitis in South Africa","volume":"8","author":"JN Jarvis","year":"2013","journal-title":"PLoS ONE"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1469-0691.2008.01984.x","article-title":"Liposomal amphotericin B: what is its role in 2008?","volume":"14","author":"F Lanternier","year":"2008","journal-title":"Clinical Microbiology and Infection"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1086\/313555","article-title":"Editorial Response: Estimating the True Cost of Amphotericin B","volume":"29","author":"JH Rex","year":"1999","journal-title":"Clinical Infectious Diseases"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/QAI.0b013e3182255dc2","article-title":"Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB\/HIV patients commencing antiretroviral therapy","volume":"58","author":"W Worodria","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref28","first-page":"49","article-title":"Immune reconstitution inflammatory syndrome in HIV-infected patients","volume":"7","author":"NF Walker","year":"2015","journal-title":"HIV\/AIDS (Auckland, NZ)"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0183656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T06:25:11Z","timestamp":1589005511000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0183656"}},"subtitle":[],"editor":[{"given":"Rodney D.","family":"Adam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,9,6]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2017,9,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0183656","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,6]]}}}